13 results on '"Burke TA"'
Search Results
2. PCV52 LOSARTAN-BASED VERSUS ATENOLOL-BASED THERAPY IN PATIENTS WITH HYPERTENSION AND LEFT VENTRICULAR HYPERTROPHY: AN ECONOMIC EVALUATION OF THE LOSARTAN INTERVENTION FOR ENDPOINT REDUCTION IN HYPERTENSION (LIFE) STUDY FOR GERMANY
3. PCV59 LIPID TESTING AMONG PATIENTS RECEIVING FIRST-EVER STATIN THERAPY IN UK GENERAL PRACTICES
4. PST2 COST-EFFECTIVENESS OF LOSARTAN IN PATIENTS WITH HYPERTENSION AND LVH: AN ECONOMIC EVALUATION FOR THE NETHERLANDS BASED ON THE LIFE-STUDY
5. PCVI5 COST-EFFECTIVENESS OF LOSARTAN IN PATIENTS WITH HYPERTENSION AND LVH IN SPAIN: AN ECONOMIC EVALUATION BASED ON THE LIFE TRIAL
6. OP0138 Relative gastrointestinal toxicity of cox-2 specific and traditional nsaids in a high-risk population from a health maintenance organisation
7. SAT0097 Success in osteoarthritis (oa) trial: celecoxib significantly reduces the risk of upper gastrointestinal (ugi) hospitalizations compared to diclofenac and naproxen in 13,274 randomised patients with oa
8. PG17: RATE OF GI DISTRESS AMONG PATIENTS TREATED WITH CELECOXIB, PLACEBO, OR NSAIDs USING THREE DIFFERENT STATISTICAL METHODS
9. PAD8: INTERPRETATION OF HAQ DISABILITY INDEX IMPROVEMENT AMONG RHEUMATOID ARTHRITIS (RA) PATIENTS IN RANDOMIZED CLINICAL TRIALS
10. TPCT6: INCREASED UPPER GASTROINTESTINAL (UGI) DISTRESS AMONG ARTHRITIS PATIENTS TREATED WITH NSAIDS AS COMPARED TO CELECOXIB AND PLACEBO
11. PAD4: CLINICALLY MEANINGFUL IMPROVEMENT OF HEALTH-RELATED QUALITY OF LIFE (HRQoL) AMONG OSTEOARTHRITIS (OA) PATIENTS
12. PAD3: RESPONSIVENESS OF WOMAC IMPROVEMENT TO PATIENTS' AND PHYSICIANS' GLOBAL ASSESSMENT (PtGA & PhGA) OF IMPROVEMENT AMONG OSTEOARTHRITIS PATIENTS (OA)
13. Regionally selective cholinergic stimulation by BRL 24924 in the human isolated gut.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.